Type I Collagen-Targeted PET Imaging in Idiopathic Pulmonary Fibrosis: First-in-Human Studies.
暂无分享,去创建一个
S. Digumarthy | M. Lanuti | R. Seethamraju | D. Izquierdo-Garcia | C. Catana | P. Caravan | S. Montesi | E. Abston | P. Désogère | L. Liang
[1] P. Caravan,et al. Molecular imaging of fibrosis: recent advances and future directions , 2019, The Journal of clinical investigation.
[2] P. Caravan,et al. Molecular Probes for Imaging Fibrosis and Fibrogenesis. , 2018, Chemistry.
[3] Amita Sharma,et al. Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis , 2018, European Respiratory Journal.
[4] B. Hutton,et al. Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF) , 2018, European Journal of Nuclear Medicine and Molecular Imaging.
[5] H. Collard,et al. Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes , 2016, Scientific Reports.
[6] A. Perkins,et al. Preclinical SPECT/CT Imaging of αvβ6 Integrins for Molecular Stratification of Idiopathic Pulmonary Fibrosis , 2013, The Journal of Nuclear Medicine.
[7] B. Hutton,et al. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[8] E. Tonveronachi,et al. 68Ga-DOTANOC PET/CT Allows Somatostatin Receptor Imaging in Idiopathic Pulmonary Fibrosis: Preliminary Results , 2010, The Journal of Nuclear Medicine.
[9] T. Wynn,et al. Cellular and molecular mechanisms of fibrosis , 2008, The Journal of pathology.